74 New, multi-directional therapies are the future of effective and safe treatment of T2DM and obesity
In DECLARE-TIMI58 with dapagliflozin, 4.4% of the patients were using GLP-1RAs at baseline, and dapagliflozin reduced the risks of MACE, HHF, and composite kidney outcomes regardless of baseline GLP-1RA use [49]
It is also important to rule out unrelated medical causes of fatigue, particularly if the tiredness feels disproportionate to the degree of appetite suppression or gastrointestinal symptoms experienced
The continent is also becoming more important to global drugmakers as non-communicable diseases such as diabetes and obesity rise alongside the continuing burden of infectious diseases
Quicksilver Scientific's heat sensitive products can be exposed to high temperatures for short periods of time (10 days) with no damage to the product
We also provide targeted functional medicine treatments for immune system disorders, which can help mitigate these symptoms